Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 4/20 | 0.33 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | EP300 | Q09472 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1884351 | 0.86 | LMNA (0.40) | ARPGRLMNAGAAMAPT | |
| SCHEMBL1880683 | 0.77 | AR (0.43) | ARPGRNR3C1NR3C2DRD2 | |
| Bromide SCHEMBL4626245 | 0.75 | AR (0.42) | ARPGRNR3C1NR3C2DRD2 | |
| SCHEMBL1878747 | 0.73 | LMNA (0.42) | ARPGRLMNAGAAMAPT | |
| SCHEMBL1878124 | 0.67 | CREBBP (0.37) | ARPGRLMNAGAAMAPT | |
| SCHEMBL12965849 | 0.64 | AR (0.45) | ARPGRLMNAGAAMAPT | |
| SCHEMBL28845154 | 0.63 | ACHE (0.36) | GAAMAPTMAOAKDM4ETSHR | |
| SCHEMBL14234586 | 0.63 | MAPT (0.39) | ARPGRLMNAGAAMAPT | |
| SCHEMBL12965982 | 0.62 | AR (0.44) | ARPGRLMNAGAAMAPT | |
| SCHEMBL11362347 | 0.60 | GAA (0.43) | ARPGRLMNAGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030074743-A1 | Hair dye composition | LION CORPORATION (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1240890-A1 | HAIR DYE COMPOSITION | Lion Corporation (JP) | 2002-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030074743-A1 | Hair dye composition | HAAO, GRHPR, CD44 | AR 248/4885PGR 1790/4885NR3C1 876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.